TG Therapeutics, Inc. (TGTX)
Q4 2013 Earnings Conference Call
March 06, 2014 08:30 AM ET
Jenna Bosco – Director-Investor Relations
Sean A. Power – Chief Financial Officer
Michael S. Weiss – Executive Chairman,...
Bonnell Aluminum, a subsidiary of Tredegar Corporation (NYSE:TG),
announced today that its new extrusion line has begun production, and
the volume ramp-up is progressing as planned.
“We are excited about our early entry to the...
Tredegar Film Products, a subsidiary of Tredegar Corporation (NYSE:TG),
today announced plans to expand its manufacturing presence in Asia. The
Company will invest $18 million in a new state-of-the-art extrusion line
Amarin (AMRN) is a biopharmaceutical company with one drug, Vascepa, on the market since January 2013. Vascepa is an ultra pure omega-3 fat acid product comprising not less than 96% EPA. It is actually marketed and sold as an adjunct...
TG Therapeutics (Nasdaq: TGTX) today announced clinical results from an ongoing first-in-human Phase I single agent study of TGR-1202, the Company's oral PI3K-Delta inhibitor being developed for the treatment of select hematologic malignancies....
Tredegar (TG) is easily overlooked, given its less-than sexy business model. It only has one analyst following the stock and the lack of understanding of the company's business keeps many investors out of the stock. Over the...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.